Page last updated: 2024-10-30

mecamylamine and Adrenal Cancer

mecamylamine has been researched along with Adrenal Cancer in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research Excerpts

ExcerptRelevanceReference
"The effect of the cholinesterase inhibitors tacrine and donepezil on A beta(25-35)-induced toxicity was investigated in rat pheochromocytoma PC12 cells by measuring the mitochondrial activity."3.70Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells. ( Nordberg, A; Svensson, AL, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Svensson, AL1
Nordberg, A1
Robinson, D1
McGee, R1

Other Studies

2 other studies available for mecamylamine and Adrenal Cancer

ArticleYear
Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
    Neuroreport, 1998, May-11, Volume: 9, Issue:7

    Topics: Adrenal Gland Neoplasms; Amyloid beta-Peptides; Animals; Cell Survival; Cholinesterase Inhibitors; D

1998
Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor of PC12 cells.
    Molecular pharmacology, 1985, Volume: 27, Issue:4

    Topics: Adrenal Gland Neoplasms; Animals; Carbachol; Cell Line; Dose-Response Relationship, Drug; Mecamylami

1985